Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 268-278

  Ramesh, Aramandla ^a   Knuckles, Maurice E ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b District of Columbia Department of Health   (United States)

Author keywords

Adduct persistence; Benzo(a)pyrene; Benzo(a)pyrene DNA adducts; Polycyclic aromatic hydrocarbons; Subchronic exposure

Indexed keywords

BENZO[A]PYRENE; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DIET; DNA ADDUCT; DNA ISOLATION; DNA REPAIR; DOSE RESPONSE; FEMALE; ISOTOPE LABELING; LIVER; LONG TERM EXPOSURE; LUNG PARENCHYMA; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; DIET; DNA ADDUCTS; FEMALE; LIVER; LUNG; MALE; PHOSPHORUS RADIOISOTOPES; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 33746218688     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.016     Document Type: Article

References (45)

1. Union of Concerned Scientists (UCS), Clean Energy: Backgrounder: The Sources Of Energy, 2003, http://www.ucsusa.org/cleanenergy/renewable_energy/page.-cfm?pageID=77 Down-loaded on July 5, 2004.
2. NTP, Report on Carcinogens, 11th ed., US Department of Health and Human Services, Public Health Service, National Toxicology Program, 2005.
3. Baird W.M., Hooven L.A., and Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45 (2005) 106-114
4. Wei Q., Gu J., Chang L., Bondy M.L., Jiang H., Hong W.K., et al. Benzo(a)pyrene diol-epoxide induced chromosomal aberrations and risk of lung cancer. Cancer Res. 56 (1996) 3975-3979
5. Ramesh A., Walker S.A., Hood D.B., Guillen M.D., Schneider H., and Weyand E.H. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int. J. Toxicol. 23 (2004) 301-333
6. Van Rooij J.G., Veeger M.M., Bodelier-Bade M.M., Scheepers P.T., and Jongeneelen F.J. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine. Int. Arch. Occup. Environ. Health 66 (1994) 55-65
7. Hattemer-Frey H.A., and Travis C.C. Benzo(a)pyrene. Environmental partitioning and human exposure. Toxicol. Ind. Health 7 (1991) 141-157
8. Sinha R., Kulldorff M., Gunter M.J., Strickland P., and Rothman N. Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2030-2034
9. Anderson K.E., Kadlubar F.F., Kulldorff M., Harnack L., Gross M., Lang N.P., et al. Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2261-2265
10. Wall K.L., Gao W., te Koppele J.M., Kauffman F.C., and Thurman R.G. The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. Carcinogenesis 12 (1991) 783-786
11. Smith L.E., Denissenko M.F., Bennett W.P., Li H., Amin S., Tang M., et al. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl Cancer Inst. 92 (2000) 803-811
12. NIH. Guidelines for the laboratoty use of chemical carcinogens. NIH Publication No. 81-2385 (1981), National Institutes of Health, US Government Printing Office, Washington, DC
13. Gupta R.C., and Randerath K. Analysis of DNA adducts by 32P labeling and thin layer chromatography. In: Friedberg E.C., and Hanawalt P.C. (Eds). DNA Repair vol. 3 (1988), Marcel Dekker Inc., New York 399-418
14. 32P-postlabeling analysis of the formation and persistence of DNA adducts in mammary glands of parous and nulliparous mice treated with benzo(a)pyrene. Carcinogenesis 13 (1992) 2009-2015
15. Nohynek G.J., and Lodola A. General principles of regulatory toxicology report writing. In: Nohynek G.J. (Ed). Presenting Toxicology Results: How to Evaluate Data and Write Reports (1996), Taylor and Francis Publishers, Philadelphia, PA 27-40
16. Lioy P.L., Waldman J.M., Greenberg A., Harkov A., and Pietarinen C. The total human environmental exposure study (THEES) to benzo(a)pyrene: comparison of the inhalation and food pathways. Arch. Environ. Health 43 (1988) 304-312
17. Roos P.H., Tschirbs S., Pfeifer F., Welge P., Hack A., Wilhelm M., et al. Risk potentials for humans of original and remediated PAH-contaminated soils: application of biomarkers of effect. Toxicology 205 (2004) 181-194
18. Culp S.J., Warbritton A.R., Smith B.A., Li E.E., and Beland F.A. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar and benzo(a)pyrene. Carcinogenesis 21 (2000) 1433-1440
19. E.D. Kroese, J.J.A. Muller, G.R. Mohn, P.M. Dortant, P.W. Wester, Tumorigenic effects in Wistar rats orally administered benzo(a)pyrene for two years (gavage studies), Implications for human cancer risks associated with oral exposure to polycyclic aromatic hydrocarbons, Report No. 658603010, National Institute of Public Health and the Environment, The Netherlands, 2001, 138 pp.
20. Weyand E.H., Modi N., and Parimo B. Evaluation of PAH: DNA adducts formation in rats fed coal tar-contaminated diets. Polycycl. Aromat. Comp. 22 (2002) 911-921
21. Ramesh A., Inyang F., Hood D.B., and Knuckles M.E. Aryl hydrocarbon hydroxylase activity in F-344 rats subchronically exposed to benzo(a)pyrene and fluoranthene through diet. J. Biochem. Mol. Toxicol. 14 (2000) 155-161
22. Ou X., and Ramos K.S. Modulation of aortic protein phosphorylation by benzo(a)pyrene: implications in PAH-induced atherogenesis. J. Biochem. Toxicol. 7 (1992) 147-154
23. 32P-postlabeling for formation of hydroxybenzo[a]-pyrene and benzo[a]pyrene-3, 6-quinone as major proximate genotoxic intermediates. J. Pharmacol. Exp. Ther. 305 (2003) 394-401
24. Faletto M.B., Maccubbin A.E., Koser P.L., Vangalio J.A., and Gurtoo H.L. Induction of aryl hydrocarbon hydroxylase and DNA adduct formation in parental and carcinogen transformed C3H/10T1/2 clone 8 cells by benzo[a]pyrene. Cancer Biochem. Biophys. 10 (1989) 197-205
25. Lodovici M., Akpan V., Casalini C., Nencini L., Pinzauti M., Marcoccia M., et al. Benzo(a)pyrene diol-epoxide-DNA adduct levels and aryl hydrocarbon hydroxylase (AHH) in human white blood cells from smokers and non-smokers. Biomarkers 4 (1999) 272-280
26. 32P-postlabelling assay in lymphocytes of lung cancer patients. Biomarkers 5 (2000) 152-157
27. Stott W.T., Kan H.L., McFadden L.G., Sparrow B.R., and Gollapudi B.B. Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats. Regul. Toxicol. Pharmacol. 39 (2004) 325-333
28. Poirer M.C., and Beland F.A. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models-implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5 (1992) 749-755
29. Talaska G., Jaeger M., Reilman R., Collins T., and Warshawsky D. Chronic topical exposure to benzo(a)pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc. Natl Acad. Sci. USA 93 (1996) 7789-7793
30. Lewtas J., Walsh D., Williams R., and Dobiáš L. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutat. Res. 378 (1997) 51-63
31. Oberdoster G. Pulmonary carcinogenicity of inhaled particles and the maximum tolerated dose. Environ. Health. Perspect. 105 Suppl. 5 (1997) 1347-1355
32. Hengstler J.G., Bogdanffy M.S., Bolt H.M., and Oesch F. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 485-520
33. Steirum R.H., van Herwijnen M.H., Hageman G.J., and Kleinjans J.C. Increased poly(ADP-ribose)polymerase activity during repair of (+/-)-anti-benzo[a]pyrene diolepoxide-induced DNA damage in human peripheral lymphocytes invitro. Carcinogenesis 15 (1994) 745-751
34. Knuckles M.E., Inyang F., and Ramesh A. Acute and subchronic oral toxicities of benzo[a]pyrene in F-344 rats. Toxicol. Sci. 61 (2001) 382-388
35. Stowers S.J., and Anderson M.W. Formation and persistence of benzo(a)pyrene metabolite-DNA adducts. Environ. Health Perspect. 62 (1985) 31-39
36. Hanawalt P.C. Genomic instability: environmental invasion and the enemies within. Mutat. Res. 400 (1998) 117-125
37. Barhoumi R., Mouneimne Y., Ramos K.S., Safe S.H., Phillips T.D., Centonze V.E., et al. Analysis of benzo(a)pyrene partitioning and cellular homeostasis in a rat liver cell line. Toxicol. Sci. 53 (2000) 264-270
38. Garg A., Beach A.C., and Gupta R.C. Interception of reactive, DNA adduct-forming metabolites present in rodent serum following carcinogen exposure: implications in biomonitoring. Teratog. Carcinog. Mutagen. 13 (1993) 151-166
39. DeBuck S.S., Augustijns P., and Muller C.P. Specific antibody modulates absorptive transport and metabolic activation of benzo(a)pyrene across Caco-2 monolayers. J. Pharmacol. Exp. Ther. 313 (2005) 640-646
40. Conney A.H., Chang R.L., Jerina D.M., and Wei S.-J.C. Studies on the metabolism of benzo(a)pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug. Metab. Rev. 26 (1994) 125-163
41. Ramesh A., Inyang F., and Knuckles M.E. Modulation of adult rat benzo(a)pyrene metabolism and DNA adduct formation by neonatal diethylstilbestrol exposure. Exp. Toxicol. Pathol. 56 (2004) 129-138
42. Ross J.A., Nelson G., Kligerman A., Erexson G., Bryant M., Earley K., et al. Formation and persistence of novel benzo(a)pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA. Cancer Res. 50 (1990) 5088-5094
43. Vepachedu S.R., Ya N., Yagi H., Sayer J.M., and Jerina D.M. Marked differences in base selectivity between DNA and the free nucleotides upon adduct formation from bay-and fjord-region diol epoxides. Chem. Res. Toxicol. 13 (2000) 883-890
44. Dreij K., Seidel A., and Jernstro{combining double acute accent}m B. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo(a)pyrene in human cells. Chem. Res. Toxicol. 18 (2005) 655-664
45. 2-deoxyguanosine adduct induces mutations at multiple sites in DNA. J. Biol. Chem. 278 (2003) 14940-14948